MoonLake Immunotherapeutics (MLTX) vs Savara (SVRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Savara (SVRA) has outperformed MoonLake Immunotherapeutics (MLTX) over the past year, gaining 42.3% versus a gain of 16.1%. Over five years, SVRA leads with a +278.3% price change compared with +8.6% for MLTX. Savara is the larger company by market cap ($1.00 billion vs $916.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MLTX | SVRA |
|---|---|---|
| Share price | $10.77 | $4.88 |
| Market cap | $916.60M | $1.00B |
| 1-day change | -1.64% | +4.95% |
| YTD return | -18.29% | -19.07% |
| 1-year return | +16.06% | +42.27% |
| 5-year return | +8.57% | +278.29% |
| EPS (TTM) | $-3.83 | $-0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $23.29 | $7.01 |
| 52-week low | $8.80 | $3.34 |
| Distance from 52-week high | -53.76% | -30.34% |
| Average volume | 1.43M | 1.81M |
| Shares outstanding | 85.11M | 205.46M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SVRA has outperformed MLTX by 26.2 percentage points over the past year.
MLTX vs SVRA FAQ
Which is bigger, MoonLake Immunotherapeutics or Savara?
Savara (SVRA) is larger, with a market capitalization of $1.00B compared with $916.60M for MoonLake Immunotherapeutics (MLTX).
Which stock has performed better over the past year, MLTX or SVRA?
SVRA returned +42.27% over the past 12 months, compared with +16.06% for MLTX (price return, excluding dividends). Past performance does not predict future results.
Are MoonLake Immunotherapeutics and Savara in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.